PHLDA1 mutations mainly occur in colorectal cancer and bladder cancer and consist of several frame-shift insertions or deletion mutations in a hotspot at position p. F252Tfs*5/Y251Tfs*5 in the pleckstrin domain. Here, PLEK is linked to urinary bladder carcinoma.